Generation of antisera to mouse insulin-like growth factor binding proteins (IGFBP)-1 to -6: comparison of IGFBP protein and messenger ribonucleic acid localization in the mouse embryo.
The insulin-like growth factor (IGF) system is an important regulator of fetal growth and differentiation. IGF bioavailability is modulated by IGF binding proteins (IGFBPs). We have generated six different antisera, directed to synthetic peptide fragments of mouse IGFBP-1 through -6. The specificity of the produced antisera was demonstrated by enzyme-linked immunosorbent assay, Western blotting, and by immunohistochemistry on sections of mouse embryos of 13.5 days post coitum. Specificity for the IGFBP-2 through -6 antisera also was confirmed immunohistochemically in liver and lung of corresponding gene deletion (knock-out) mutant mice and wild-type litter mates. Immunohistochemistry and messenger RNA (mRNA) in situ hybridization on sections of mouse embryos of 13.5 days post coitum revealed tissue-specific expression patterns for the six IGFBPs. The only site of IGFBP-1 protein and mRNA production was the liver. IGFBP-2, -4, and -5 protein and mRNA were detected in various organs and tissues. IGFBP-3 and -6 protein and mRNA levels were low. In several tissues, such as lung, liver, kidney, and tongue, more than one IGFBP (protein and mRNA) could be detected. Differences between mRNA and protein localization were extensive for IGFBP-3, -5, and -6, suggesting that these IGFBPs are secreted and transported. These results confirm the different spatial localization of the IGFBPs, on the mRNA and protein level. The overlapping mRNA and protein localization for IGFBP-2 and -4, on the other hand, may indicate that these IGFBPs also function in an auto- or paracrine manner.
van Kleffens
M
M
Laboratory of Pediatrics, Erasmus University Rotterdam, Rotterdam, The Netherlands.
Groffen
C A
CA
Dits
N F
NF
Lindenbergh-Kortleve
D J
DJ
Schuller
A G
AG
Bradshaw
S L
SL
Pintar
J E
JE
Zwarthoff
E C
EC
Drop
S L
SL
van Neck
J W
JW
D000595:Amino Acid Sequence; D000818:Animals; D000918:Antibody Specificity; D004622:Embryo, Mammalian / Q000737:chemistry*; D007106:Immune Sera / Q000096:biosynthesis*; D007150:Immunohistochemistry; D018970:Insulin-Like Growth Factor Binding Protein 1 / Q000032:analysis / Q000737:chemistry / Q000276:immunology; D018971:Insulin-Like Growth Factor Binding Protein 2 / Q000032:analysis / Q000737:chemistry / Q000276:immunology; D018972:Insulin-Like Growth Factor Binding Protein 3 / Q000032:analysis / Q000737:chemistry / Q000276:immunology; D018974:Insulin-Like Growth Factor Binding Protein 4 / Q000032:analysis / Q000737:chemistry / Q000276:immunology; D018975:Insulin-Like Growth Factor Binding Protein 5 / Q000032:analysis / Q000737:chemistry / Q000276:immunology; D018976:Insulin-Like Growth Factor Binding Protein 6 / Q000032:analysis / Q000737:chemistry / Q000276:immunology; D018969:Insulin-Like Growth Factor Binding Proteins / Q000032:analysis* / Q000235:genetics* / Q000276:immunology; D004915:Leukemia, Erythroblastic, Acute; D051379:Mice; D008969:Molecular Sequence Data; D012333:RNA, Messenger / Q000032:analysis*; D014407:Tumor Cells, Cultured
D007106:Immune Sera; D018970:Insulin-Like Growth Factor Binding Protein 1; D018971:Insulin-Like Growth Factor Binding Protein 2; D018972:Insulin-Like Growth Factor Binding Protein 3; D018974:Insulin-Like Growth Factor Binding Protein 4; D018975:Insulin-Like Growth Factor Binding Protein 5; D018976:Insulin-Like Growth Factor Binding Protein 6; D018969:Insulin-Like Growth Factor Binding Proteins; D012333:RNA, Messenger